GEN Exclusives

More »

GEN News Highlights

More »
Apr 15, 2010

Scientists Reveal Role of a LincRNA in Breast Cancer

  • A group of researchers have figured out how levels of a specific long intervening noncoding RNA (lincRNA) in primary breast tumors regulate metastasis and tumor invasiveness. They say that increased levels of the lincRNA called HOTAIR resulted in reprogramming of epigenetic components of breast tumors, inducing cancer invasiveness and metastasis. Conversely, suppression of HOTAIR inhibited cancer invasiveness.

    The study is titled “Long Non-coding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis” and appears in the April 15 edition of Nature.

    Life Technologies’ Applied Biosystems TaqMan® Non-Coding RNA Assays were used to measure expression levels of lincRNAs in a specific region of the genome in different breast cancer samples. The researchers found that the regulatory function of lincRNAs becomes impaired during breast cancer progression.

    Further, expression levels of HOTAIR increased in primary breast tumors and during metastasis. Combining this data with results of other experiments in the study, the researchers report that high levels of HOTAIR in breast cancer tumors contribute to the epigenetic silencing of genes that suppress metastasis.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?